These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11503553)

  • 1. Case reports of low dose cyclosporine. A therapy in adult minimal change nephrotic syndrome.
    Woo KT; Chew ST; Vathsala A; Chiang GS
    Ann Acad Med Singap; 2001 Jul; 30(4):430-5. PubMed ID: 11503553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Complete remission of steroid-resistant minimal-change nephrotic syndrome by cyclosporin after additional low-density lipoprotein apheresis treatment].
    Okada T; Takahashi H; Ogura M; Nakao T; Shimizu T
    Nihon Jinzo Gakkai Shi; 1996 Jan; 38(1):46-51. PubMed ID: 8855137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined cyclosporine and prednisolone therapy using cyclosporine blood concentration monitoring for adult patients with new-onset minimal change nephrotic syndrome: a single-center pilot randomized trial.
    Shirai S; Imai N; Sueki S; Matsui K; Tominaga N; Sakurada T; Yasuda T; Kimura K; Shibagaki Y
    Clin Exp Nephrol; 2018 Apr; 22(2):283-290. PubMed ID: 28699032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Low-dose cyclosporin therapy combined with prednisolone for relapsing minimal change nephrotic syndrome in adults].
    Koike M; Honda K; Tsukada M; Itabashi M; Suzuki K; Uchida K; Nitta K; Yumura W; Nihei H
    Nihon Jinzo Gakkai Shi; 2002; 44(5):447-52. PubMed ID: 12216477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Favorable outcome of low-dose cyclosporine after pulse methylprednisolone in Japanese adult minimal-change nephrotic syndrome.
    Matsumoto H; Nakao T; Okada T; Nagaoka Y; Takeguchi F; Tomaru R; Iwasawa H
    Intern Med; 2004 Aug; 43(8):668-73. PubMed ID: 15468963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
    Ehrich JH; Geerlings C; Zivicnjak M; Franke D; Geerlings H; Gellermann J
    Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
    Maas RJ; Deegens JK; Beukhof JR; Reichert LJ; Ten Dam MA; Beutler JJ; van den Wall Bake AWL; Rensma PL; Konings CJ; Geerse DA; Feith GW; Van Kuijk WH; Wetzels JF
    Am J Kidney Dis; 2017 May; 69(5):637-646. PubMed ID: 28089478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous remission of therapy-resistant minimal change nephritis in an adult woman 12 years after onset of the disease.
    Raml A; Sedlak M; Schmekal B; Stuby U; Syre' G; Biesenbach G
    Wien Med Wochenschr; 2006 Jul; 156(13-14):421-5. PubMed ID: 16937046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of high-age minimal change nephrotic syndrome relapse after 18-year remission and effective treatment with steroid and cyclosporin combined therapy].
    Yoshimoto K; Wada T; Iwata Y; Sakai N; Shimizu M; Furuichi K; Yokoyama H; Kobayashi K
    Nihon Jinzo Gakkai Shi; 2000 Oct; 42(8):640-3. PubMed ID: 11195400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the efficacy of cyclosporine A treatment in idiopathic nephrotic syndrome in children].
    Wyszyńska T; Ksiazek J; Wieteska-Klimczak A; Gorzkowska-Paczwa M; Dorywalski T; Tysarowska A
    Pol Merkur Lekarski; 2001 Aug; 11(62):140-3. PubMed ID: 11757213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of Japanese children with complicated minimal change nephrotic syndrome treated with mycophenolate mofetil after cyclosporine.
    Fujinaga S; Hirano D; Nishino T; Umeda C; Watanabe Y; Nakagawa M
    Pediatr Nephrol; 2019 Nov; 34(11):2417-2421. PubMed ID: 31435725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complete remission of minimal change nephrotic syndrome with type 2 diabetes mellitus treated by microemulsion formulation of cyclosporin and fluvastatin].
    Makibayashi K; Fukatsu A; Kita T
    Nihon Jinzo Gakkai Shi; 2002 Mar; 44(2):109-13. PubMed ID: 11974950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C1-C2 point monitoring of low-dose cyclosporin a given as a single daily dose in children with steroid-dependent relapsing nephrotic syndrome.
    Nakahata T; Tanaka H; Tsugawa K; Kudo M; Suzuki K; Ito E; Waga S
    Clin Nephrol; 2005 Oct; 64(4):258-63. PubMed ID: 16240896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis.
    Ittel TH; Clasen W; Fuhs M; Kindler J; Mihatsch MJ; Sieberth HG
    Clin Nephrol; 1995 Sep; 44(3):156-62. PubMed ID: 8556831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy.
    Goumenos DS; Kalliakmani P; Tsakas S; Sotsiou F; Vlachojannis JG
    Clin Nephrol; 2004 Jan; 61(1):17-24. PubMed ID: 14964453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of cyclosporine combination therapy for new-onset minimal change nephrotic syndrome in adults.
    Fujiwara A; Hirawa N; Kobayashi Y; Yatsu K; Katsumata M; Ehara Y; Okuyama Y; Yutoh J; Kaneda T; Fujita M; Yamamoto Y; Saka S; Toya Y; Yasuda G; Umemura S
    Clin Exp Nephrol; 2015 Apr; 19(2):240-6. PubMed ID: 24771147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open-label randomized controlled trial of low-dose corticosteroid plus enteric-coated mycophenolate sodium versus standard corticosteroid treatment for minimal change nephrotic syndrome in adults (MSN Study).
    Rémy P; Audard V; Natella PA; Pelle G; Dussol B; Leray-Moragues H; Vigneau C; Bouachi K; Dantal J; Vrigneaud L; Karras A; Pourcine F; Gatault P; Grimbert P; Ait Sahlia N; Moktefi A; Daugas E; Rigothier C; Bastuji-Garin S; Sahali D;
    Kidney Int; 2018 Dec; 94(6):1217-1226. PubMed ID: 30385039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of remission following a single dose of rituximab alone in a patient with minimal change nephrotic syndrome.
    Amemiya N; Takei T; Kojima C; Nokiba H; Itabashi M; Nitta K
    Clin Exp Nephrol; 2011 Dec; 15(6):933-6. PubMed ID: 21823044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrotoxicity of once-daily cyclosporine A in minimal change nephrotic syndrome.
    Fujinaga S; Hirano D; Murakami H; Ohtomo Y; Shimizu T; Kaneko K
    Pediatr Nephrol; 2012 Apr; 27(4):671-4. PubMed ID: 22198072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.